Regeneron Pharmaceuticals, Inc. (REGN)
NASDAQ: REGN · Real-Time Price · USD
762.00
+5.19 (0.69%)
Nov 18, 2024, 4:00 PM EST - Market closed
Regeneron Pharmaceuticals Analyst Ratings
Total Analysts
24
Consensus Rating
Buy
Price Target
$1,110.63
Upside
+45.75%
Ratings History
| Analyst | Firm | Rating | Rating | Action | Price Target | Upside | Date |
|---|---|---|---|---|---|---|---|
| Wolfe Research | Wolfe Research | Buy Initiates $1,150 | Buy | Initiates | $1,150 | +50.92% | Nov 15, 2024 |
| Citigroup | Citigroup | Hold Initiates $895 | Hold | Initiates | $895 | +17.45% | Nov 14, 2024 |
| Oppenheimer | Oppenheimer | Buy Maintains $1,150 → $1,000 | Buy | Maintains | $1,150 → $1,000 | +31.23% | Nov 6, 2024 |
| Morgan Stanley | Morgan Stanley | Buy Maintains $1,235 → $1,184 | Buy | Maintains | $1,235 → $1,184 | +55.38% | Nov 1, 2024 |
| RBC Capital | RBC Capital | Buy Maintains $1,260 → $1,215 | Buy | Maintains | $1,260 → $1,215 | +59.45% | Nov 1, 2024 |
| Barclays | Barclays | Buy Maintains $1,080 → $1,065 | Buy | Maintains | $1,080 → $1,065 | +39.76% | Nov 1, 2024 |
| Piper Sandler | Piper Sandler | Buy Maintains $1,242 → $1,195 | Buy | Maintains | $1,242 → $1,195 | +56.82% | Nov 1, 2024 |
| BMO Capital | BMO Capital | Buy Maintains $1,300 → $1,190 | Buy | Maintains | $1,300 → $1,190 | +56.17% | Nov 1, 2024 |
| Truist Securities | Truist Securities | Strong Buy Maintains $1,137 → $1,126 | Strong Buy | Maintains | $1,137 → $1,126 | +47.77% | Nov 1, 2024 |
| RBC Capital | RBC Capital | Buy Reiterates $1,260 | Buy | Reiterates | $1,260 | +65.35% | Oct 25, 2024 |
| Evercore ISI Group | Evercore ISI Group | Buy Maintains $1,250 → $1,175 | Buy | Maintains | $1,250 → $1,175 | +54.20% | Oct 24, 2024 |
| JP Morgan | JP Morgan | Buy Maintains $1,200 → $1,150 | Buy | Maintains | $1,200 → $1,150 | +50.92% | Oct 24, 2024 |
| Cantor Fitzgerald | Cantor Fitzgerald | Hold Reiterates $1,015 | Hold | Reiterates | $1,015 | +33.20% | Oct 23, 2024 |
| Barclays | Barclays | Buy Maintains $1,220 → $1,080 | Buy | Maintains | $1,220 → $1,080 | +41.73% | Oct 23, 2024 |
| Wells Fargo | Wells Fargo | Buy Maintains $1,200 → $1,050 | Buy | Maintains | $1,200 → $1,050 | +37.80% | Oct 22, 2024 |
| RBC Capital | RBC Capital | Buy Reiterates $1,260 | Buy | Reiterates | $1,260 | +65.35% | Oct 22, 2024 |
Upgrade to Pro
Get stock forecasts from Wall Street's highest rated professionals
Get much more with Stock Analysis Pro
- Investment ideas from the top Wall Street analysts
- Unlimited access to all data and tools
- Advanced analyst filtering and sorting options
- Up to 10 years of analyst rating history
Analyst Star Rankings
Our analyst star rankings are based on these four factors
- Success Rate
- The percentage of ratings that are profitable.
- Average Return
- The average percentage return within one year of the rating.
- Rating Count
- The more ratings the analyst has provided, the higher the score.
- Recency
- Ratings provided within the past year contribute to a higher score.